Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Harvard University
Harvard University
Activities:
Training & Education
Research & Development
X
LinkedIn
Trending Articles
Neopac showcases latest tube, dispensing and cap innovations at Pharmapack Paris
Highlights include company’s reduced material LowPro caps and world’s smallest child resistant tube
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
You need to be a subscriber to read this article.
Click here
to find out more.
Parenteral preparations: formulation challenges
Parenteral preparations are defined as solutions, suspensions, emulsions for injection or infusion, powders for injection or infusion, gels for injection and implants. They are...
Lonza’s capsule delivers acid-sensitive ingredients to the intestine
The capsule can simplify the manufacturing process to accelerate drug development and expedite first-in-human timelines
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Research & Development
New Harvard consortium focuses on advanced bioproduction
The overarching mission of the collaboration is to catalyse the development of transformative therapies by shortening the path between research and clinical application
Research & Development
Malaysian scientists join Harvard team to create effective nano drugs
Will assess how nanomedicine particles behave in the body, what attaches to them to form a coating, where the drug accumulates and how it interacts with target and non-target cells
Drug Delivery
Drug-device combination opens potential path to treat stroke
Obstructed blood clots in the brain could be cleared using a device that opens a small channel through the blockage in combination with a clot-busting drug
Regulatory
Wyss Institute introduces new biosafety assessment process
The pre-emptive biosafety model looks to cover potential biosafety risks from new biotechnologies
Research & Development
Patient stem cells used to make ‘heart disease-on-a-chip’ as testing platform for drugs
Research could signify a big step forward for personalised medicine
Subscribe now